- Anthropic aims to raise up to 74 billion USD in its Nasdaq initial public offering under the ticker ANT.
- The company targets a market capitalization of approximately 1 trillion USD to 1.4 trillion USD on a fully diluted basis.
- Third-quarter revenue reached nearly 17 billion USD, driven by strong adoption of AI models in software engineering.
- Anthropic shares are expected to begin trading on Thursday, 19 November 2025.
- Anthropic aims to raise up to 74 billion USD in its Nasdaq initial public offering under the ticker ANT.
- The company targets a market capitalization of approximately 1 trillion USD to 1.4 trillion USD on a fully diluted basis.
- Third-quarter revenue reached nearly 17 billion USD, driven by strong adoption of AI models in software engineering.
- Anthropic shares are expected to begin trading on Thursday, 19 November 2025.
Anthropic, creator of the Claude model and arguably the largest artificial intelligence laboratory, began investor meetings on Tuesday, November 10, ahead of its debut on the Nasdaq. The company and some existing shareholders intend to sell 825 million shares at a price ranging from $70 to $78. This puts the offering size between $57.8 billion and $64.4 billion, and if underwriters exercise their option for an additional allotment (123.75 million shares), the offer could grow to approximately $74 billion. This is the second-largest initial public offering in history, second only to SpaceX's debut earlier this year. Shares will trade under the ticker symbol ANT. This means the company's market capitalization could reach around $1 trillion under the current offer. That is a fairly reasonable figure given previous astronomical valuations reaching $1.5–$2 trillion, but at the same time, amid the current sell-off in AI stocks, a relatively safe move. What does the prospectus look like, and when should we expect the debut?

Astronomical Revenue Growth Rate
The prospectus reveals the company's full financials for the first time. Third-quarter revenue reached nearly $17 billion, compared to $1.4 billion a year earlier—a roughly twelvefold increase. The annualized revenue run rate reached approximately $81 billion at the end of October, up $10 billion from the previous month. The number of customers paying over $100,000 annually grew to 11,900.
The main growth driver is the application of models to software engineering. According to the prospectus, more than 90% of code changes within the company itself were written by Claude. Anthropic is also developing solutions for specific industries, primarily healthcare and life sciences.
Profitability Has Not Yet Stabilized
In the second quarter, the company generated an operating profit for the first time ($974 million), but recorded a loss again in the third quarter ($567 million). Operating expenses surged 292% year-over-year to $17.5 billion. The loss was primarily driven by roughly $5 billion in short-term compute capacity commitments and $2 billion in non-cash charges related to a donation program.
Signs of pricing pressure are also beginning to emerge. Lower prices for new models and discounts for certain clients reduced third-quarter revenue growth by approximately $600 million. Competition is also rising from lower-cost open-weights models, including those from China.

Largest Risk: Scale of Commitments
A portion of these agreements involves transactions with companies that are also shareholders in the business. Google, Amazon, and Microsoft act as investors, customers, and compute providers. Such interconnected relationships are important to keep in mind when evaluating how much demand is truly independent.

Market Context
At a valuation between $900 billion and $1 trillion, Anthropic would trade at 11 to 12 times its annualized revenue run rate. This is lower than Nvidia (16x), Broadcom (21x), or OpenAI's private market valuation (around 18x at $1.25 trillion), and comparable to Microsoft or TSMC. 
However, it is important to remember that the run rate reflects performance in the most recent month rather than full-year revenue. Annualizing third-quarter figures alone ($17 billion times 4), the valuation multiple rises to 13 to 15 times. Furthermore, this is a company only beginning to reach profitability, in contrast to mature tech giants.

What to Watch For?
The IPO arrives following a sharp sell-off in artificial intelligence stocks. The Nasdaq 100 has fallen nearly 10% in the past month, Nvidia is down over 20%, and investors remain concerned about stricter data center regulations. News of the IPO helped bolster market sentiment, however: on Monday, the Nasdaq 100 rose 3.4%, and shares of Anthropic partners surged on Tuesday, with AMD up 13% and Broadcom climbing nearly 9%.
Anthropic is organized as a public benefit corporation, balancing shareholder returns with its mission to develop AI responsibly. An independent trust, the Long-Term Benefit Trust, elects the majority of the board of directors, while the founders hold 50.1% of the voting power on remaining matters through a dedicated share class. Investors buying into the offering will therefore have limited governance control. In its prospectus, Anthropic explicitly cautions that the technology could pose "catastrophic or existential risks to humanity" if not developed with adequate safeguards.
The offering is led by Goldman Sachs and Morgan Stanley, alongside 20 other underwriting banks. Key factors will be whether investor demand supports pricing at the top of the range and how the stock performs in its initial trading sessions. The debut will serve as a major test of investor willingness to pay premium valuations for AI growth following the recent market pullback, potentially setting a benchmark for OpenAI's anticipated 2027 IPO.
At the upper bound of the price range, Anthropic would be valued at approximately $1 trillion, and around $900 billion at the lower end. This puts its valuation on par with Walmart or Berkshire Hathaway, and below Meta and Broadcom. Nearly the entire offering consists of new primary shares, raising between $56 billion and $62.5 billion for the company. An additional $26 billion is committed by strategic partners, including AMD, Broadcom, Nvidia, and Google.

One Trillion or 1.4 Trillion?
Reports reference two valuation metrics, both of which are accurate. Approximately $1 trillion reflects the market capitalization at $78 per share based solely on outstanding shares. The ~$1.4 trillion figure represents the fully diluted valuation, accounting for employee stock options, unvested share grants, and shares reserved for the donation program. Because these shares will eventually enter circulation, the higher figure is more relevant for long-term investors. At $1.4 trillion, Anthropic would trade at roughly 17 times its annualized revenue run rate—higher than Nvidia and roughly in line with OpenAI's private valuation. From that perspective, the offering appears less discounted.

When Is the Debut?
According to Bloomberg reports, final IPO pricing is expected on Wednesday, November 18. Since U.S. trading typically commences the following day, Anthropic shares are likely to begin trading on Thursday, November 19. The company has not yet officially confirmed the date, and changes in broader market conditions could adjust the schedule.
Daily summary: CPI reading hits markets, hawkish Fed and Wall Street selloff
US OPEN: Higher CPI Inflation Cools Sentiment, Anthropic Targets $1.4 Trillion Valuation
📈Morning Wrap: Tech Bounce and Oil Price Collapse Following Signals of De-escalation Around Iran
US OPEN: Falling Oil Prices and Dip-Buying Fuel Rebound as Nvidia falls
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.